The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 23, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Mar 23, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Mar 23, 2023 | Yoo David Jin | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Mar 23, 2023 | Yoo David Jin | Chief Financial Officer | Grant(A) | 20K | — | $0 |
| Mar 23, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Mar 23, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 21, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 225K | — | $0 |
| Feb 21, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 5K | — | $0 |
| Feb 21, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 225K | — | $0 |
| Feb 21, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 5K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Grant(A) | 430K | $10.00 | $4.3M |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 225K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 30K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Buy(P) | 430K | $10.00 | $4.3M |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Hwang Kuk Hyoun | Chief Executive Officer, Director, 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Grant(A) | 430K | $10.00 | $4.3M |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 225K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 30K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Buy(P) | 430K | $10.00 | $4.3M |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Bellevue Global Life Science Investors LLC | 10% Owner | Other(J) | 20K | — | $0 |
| Feb 14, 2023 | Euh Hosun | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Park Jin Whan | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Roberts Rad | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Chung In Chul | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Chung In Chul | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Reed Steven | Director | Grant(A) | 20K | — | $0 |
| Feb 14, 2023 | Reed Steven | Director | Grant(A) | 20K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).